These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11507083)

  • 1. Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias.
    Caceres-Cortes JR; Alvarado-Moreno JA; Waga K; Rangel-Corona R; Monroy-Garcia A; Rocha-Zavaleta L; Urdiales-Ramos J; Weiss-Steider B; Haman A; Hugo P; Brousseau R; Hoang T
    Cancer Res; 2001 Aug; 61(16):6281-9. PubMed ID: 11507083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Steel factor].
    Cáceres-Cortés JR
    Rev Invest Clin; 1997; 49(6):507-14. PubMed ID: 9528312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Product of the Steel locus can replace leukemic cell interaction.
    Cáceres-Cortés JR; Hoang T
    Cancer Res; 1992 Oct; 52(19):5208-12. PubMed ID: 1382839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor.
    Krystal GW; Hines SJ; Organ CP
    Cancer Res; 1996 Jan; 56(2):370-6. PubMed ID: 8542594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a functional kit receptor in melanoma, breast, and lung carcinoma cells.
    DiPaola RS; Kuczynski WI; Onodera K; Ratajczak MZ; Hijiya N; Moore J; Gewirtz AM
    Cancer Gene Ther; 1997; 4(3):176-82. PubMed ID: 9171936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
    Beghini A; Cairoli R; Morra E; Larizza L
    Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1.
    Bellone G; Silvestri S; Artusio E; Tibaudi D; Turletti A; Geuna M; Giachino C; Valente G; Emanuelli G; Rodeck U
    J Cell Physiol; 1997 Jul; 172(1):1-11. PubMed ID: 9207920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells.
    Vinante F; Rigo A; Vincenzi C; Ricetti MM; Marrocchella R; Chilosi M; Cassatella MA; Bonazzi L; Pizzolo G
    Leukemia; 1993 Oct; 7(10):1552-6. PubMed ID: 8412317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of p145c-kit function in cells of patients with acute myeloblastic leukemia.
    Bühring HJ; Herbst R; Kostka G; Bossenmaier B; Bartke I; Kropshofer H; Kalbacher H; Busch FW; Müller CA; Schlessinger J
    Cancer Res; 1993 Sep; 53(18):4424-31. PubMed ID: 7689935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between c-Kit expression and proliferation in acute myeloblastic leukemia cell lines.
    Tohda S; Yang GS; Ashman LK; McCulloch EA; Minden MD
    J Cell Physiol; 1993 Feb; 154(2):410-8. PubMed ID: 7678840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential.
    Bellone G; Carbone A; Sibona N; Bosco O; Tibaudi D; Smirne C; Martone T; Gramigni C; Camandona M; Emanuelli G; Rodeck U
    Cancer Res; 2001 Mar; 61(5):2200-6. PubMed ID: 11280787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts.
    Riccioni R; Diverio D; Mariani G; Buffolino S; Riti V; Saulle E; Petrucci E; Cedrone M; Lo-Coco F; Foà R; Peschle C; Testa U
    Stem Cells; 2007 Aug; 25(8):1862-71. PubMed ID: 17446561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cells.
    Scappini B; Onida F; Kantarjian HM; Dong L; Verstovsek S; Keating MJ; Beran M
    Clin Cancer Res; 2001 Dec; 7(12):3884-93. PubMed ID: 11751479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-kit as a target in the treatment of acute myelogenous leukemia.
    Advani AS
    Curr Hematol Rep; 2005 Jan; 4(1):51-8. PubMed ID: 15610660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local presentation of Steel factor increases expression of c-kit immunoreactive interstitial cells of Cajal in culture.
    Rich A; Miller SM; Gibbons SJ; Malysz J; Szurszewski JH; Farrugia G
    Am J Physiol Gastrointest Liver Physiol; 2003 Feb; 284(2):G313-20. PubMed ID: 12388202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia.
    Auewarakul CU; Lauhakirti D; Promsuwicha O; Munkhetvit C
    Ann Hematol; 2006 Feb; 85(2):108-12. PubMed ID: 16320053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of stem cell factor and c-kit in human malignant fibrous histiocytoma cell line (TNMY1).
    Nakatani T; Marui T; Yamamoto T; Hitora T; Akisue T; Kawamoto T; Nagira K; Fujita I; Matsumoto K; Yoshiya S; Kurosaka M
    Anticancer Res; 2003; 23(3B):2329-33. PubMed ID: 12894511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
    Shivakrupa R; Bernstein A; Watring N; Linnekin D
    Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
    Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
    Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.